Please log in to view this page
Username
Password
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
